MAM
TARS icon

Martingale Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Martingale Asset Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$573K Buy
9,101
+1
+0% +$64 0.01% 628
2026
Q1 		$638K Buy
+9,100
New +$636K 0.02% 592
2022
Q4 		– Sell
-14,329
Closed -$246K – 884
2022
Q3 		$246K Sell
14,329
-20
-0.1% -$318 ﹤0.01% 746
2022
Q2 		$210K Buy
+14,349
New +$215K ﹤0.01% 802

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Martingale Asset Management's TARS Position: Q2 2026 in Review

Martingale Asset Management increased its Tarsus Pharmaceuticals (TARS) stake by 0.01% in Q2 2026, buying an estimated $64 and bringing the position to 9,101 shares worth $573K. The position accounts for 0.01% of the portfolio, ranked #628.

Martingale Asset Management first reported a position in TARS in Q2 2022 and has held it in 4 quarters since. The position peaked at $638K in Q1 2026. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Martingale Asset Management held 9,101 shares of Tarsus Pharmaceuticals worth $573K as of Q2 2026.
  • Martingale Asset Management bought 1 Tarsus Pharmaceuticals share in Q2 2026, an estimated $64.
  • Tarsus Pharmaceuticals made up 0.01% of Martingale Asset Management's portfolio in Q2 2026, its #628 holding.
  • Martingale Asset Management first reported a position in Tarsus Pharmaceuticals in Q2 2022 and has held it in 4 quarters since.
  • Martingale Asset Management's Tarsus Pharmaceuticals position peaked at $638K in Q1 2026.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.